Status: current, Not sufficiently defined by necessary conditions definition status. Date: 09-Jan 2013. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
71861801000001112 | Saxagliptin 2.5mg / Metformin 1g tablets (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
71861901000001118 | Saxagliptin 2.5mg / Metformin 1g tablets | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Komboglyze 2.5mg/1000mg tablets (DE Pharmaceuticals) | Is a | True | Saxagliptin 2.5mg / Metformin 1g tablets | Inferred relationship | Existential restriction modifier | |
Komboglyze 2.5mg/1000mg tablets (Mawdsley-Brooks & Company Ltd) | Is a | True | Saxagliptin 2.5mg / Metformin 1g tablets | Inferred relationship | Existential restriction modifier | |
Komboglyze 2.5mg/1000mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) | Is a | True | Saxagliptin 2.5mg / Metformin 1g tablets | Inferred relationship | Existential restriction modifier | |
Saxagliptin 2.5mg / Metformin 1g tablets 56 tablet | Has VMP | True | Saxagliptin 2.5mg / Metformin 1g tablets | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets